|
Resolution: standard / high Figure 2.
This graph illustrates the estimated GFR versus time (in months) prior to and after
completion of the 6-month FONT Treatment Period in patients assigned to adalimumab.
Peyser et al. BMC Nephrology 2010 11:2 doi:10.1186/1471-2369-11-2 |
